PO-07. Outcomes of second hematopoietic stem cell transplantation in children with malignant and non-malignant blood disorders: a single center study

Cellular Therapy and Transplantation

article

Larisa V. Vakhonina¹  Anna A. Vlasova¹  Dmitry E. Klevakin¹  Grigory A. Tsaur¹  Tatiana Yu. Verzhbitskaya¹  Anna S. Demina¹  Larisa G. Fechina¹ 

[1] Sverdlovsk Regional Clinical Children’s Hospital;Sverdlovsk Institute of Medical Cell Technologies

关键词: Children;    leukemia;    non-malignant conditions;    hematopoietic stem cell transplantation;    allogeneic;    repeated.;   

DOI  :  10.18620/ctt-1866-8836-2022-11-3-1-132

学科分类：肿瘤学

来源: Universitaetsklinikum Hamburg - Eppendorf / University Medical Center Hamburg - Eppendorf

【 摘 要 】

The main reasons for allogeneic hemopoietic stem cell transplantation (allo-HSCT) failure are relapses for malignant and graft failure/rejection for non-malignant conditions. However, the second allogeneic transplant may be a clinical option in these situations.

【 授权许可】

CC BY